Repros Therapeutics, Inc. (RPRX) Posts Wider than Expected Q4 Loss

March 18, 2013 9:30 AM

Repros Therapeutics, Inc. (NASDAQ: RPRX) reported Q4 EPS of ($0.47) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found